Forbes contributors publish independent expert analyses and insights. William A. Haseltine, Ph.D., covers genomics and regenerative medicine Non-invasive prenatal testing, or NIPT, now shapes critical ...
Myriad Genetics, Inc. has announced the early access launch of its FirstGeneTM Multiple Prenatal Screen, which provides a comprehensive prenatal genetic risk assessment through a single blood draw, ...
While noninvasive prenatal testing (NIPT) has revolutionized prenatal diagnostics by allowing the detection of a number of genetic problems in a fetus, it is currently limited and thus misses many ...
Myriad Genetics, Inc. has launched a new educational website called "Know More Sooner," aimed at providing detailed information about reproductive and prenatal genetic testing. The site seeks to ...
The NIPT market's growth opportunities lie in expanding its clinical applications, leveraging advanced sequencing technologies, and increasing adoption for low-risk pregnancies. Rising maternal age, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results